Most Thais Back PM’s Plan to Reclassify Cannabis as Drug: Survey
(Bloomberg) -- The majority of Thais support Prime Minister Srettha Thavisin’s plan to reclassify cannabis as a narcotic and limit its use to medical purposes, according to a survey.
Most Read from Bloomberg
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Iran State TV Says ‘No Sign of Life’ at Helicopter Crash Site
Jamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’
One of the Last Big Bears on Wall Street Turns Bullish on US Stocks
ASML and TSMC Can Disable Chip Machines If China Invades Taiwan
About 76% of people who took part in a survey said they “totally agreed” or “rather agreed” with Srettha’s policy u-turn to re-criminalize the plant, according to a survey by the National Institute of Development Administration. The poll was conducted via phone between May 14 and 15 among 1,310 Thai nationals aged 18 and above. About 23.4% disagreed with the move, while 0.9% declined to answer or said they had no interest in the issue.
The proposed policy reversal is another blow for Thailand’s nascent cannabis industry after decriminalization was pitched as a way to boost agricultural income and the country’s wellness tourism industry. Srettha has vowed to restrict the use of marijuana to medical purposes.
About 75% of respondents support the restricted use of cannabis for medical reasons, while 19% said the government shouldn’t implement any policies to support the use of the plant, the poll showed.
Cannabis advocacy groups last week rallied to protest Srettha’s order, asking the government to reconsider the plan to protect the interest of a rising industry and a large community of growers.
Almost 8,000 dispensaries and a large number of consumer-agro firms have cropped up across Thailand, selling everything from cannabis buds to oil extracts and candy infused with the plant’s active chemicals.
Most Read from Bloomberg Businessweek
Millennium Covets Citadel-Size Commodities Gains, Just Not the Risk
Netflix Had a Password-Sharing Problem. Greg Peters Fixed It
©2024 Bloomberg L.P.
